[MO38] Mini-Oral Session 38　Cross-sectional Program 4（PhaseⅠ trial and Precision medicine）
【E】

[MO38-4] Frequency and clinical outcome of cancer-related genetic alterations detected by CGP tests at Shizuoka Cancer Center

^○Nobuaki Mamesaya^1,2, Masakuni Serizawa³, Eriko Miyawaki^1,2, Ryo Koh^1,2, Kunihiro Fushiki^2,4, Hiromitsu Shirasu^2,4, Nobuhiro Kado^2,5, Rina Umehara³, Kana Kunitomo², Nao Kawamura², Naomi Fukuzaki², Satomi Higashigawa², Yoshimi Kiyozumi², Hiroyuki Matsubayashi², Hirofumi Yasui^2,4, Hirotsugu Kenmotsu^1,2 (1.Division of Thoracic Oncology, Shizuoka Cancer Center, 2.Division of Genetic Medicine Promotion, Shizuoka Cancer Center, 3.Division of Drug Discovery & Development, Shizuoka Cancer Center, 4.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 5.Division of Gynecology, Shizuoka Cancer Center)